Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Last 12 months price action with 12-month analyst target path
As of May 6, 2026, Eagle Bancorp, Inc. (EGBN) has a Wall Street consensus price target of $28.67, based on estimates from 14 covering analysts. With the stock currently trading at $26.51, this represents a potential upside of +8.1%. The company has a market capitalization of $808M.
Analyst price targets range from a low of $25.00 to a high of $32.00, representing a 24% spread in expectations. The median target of $29.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 6 analysts rating the stock as a Buy or Strong Buy,8 rating it Hold, and 0 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, EGBN trades at a trailing P/E of -6.3x and forward P/E of 15.9x. Analysts expect EPS to grow +139.3% over the next year.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationSide-by-side business, growth, and profitability comparison vs Berkshire Hathaway Inc..
Start ComparisonQuick answers to the most common questions about buying EGBN stock.
The consensus price target for EGBN is $28.67, close to the current price of $26.51 (8.1% implied move). Based on 14 analyst estimates, the stock appears fairly valued near current levels.
EGBN has a consensus rating of "Hold" based on 14 Wall Street analysts. The rating breakdown is mixed, with 8 Hold ratings making up the largest segment. The consensus 12-month price target of $28.67 implies 8.1% upside from current levels.
With a forward P/E of 15.9124x, EGBN trades at a relatively low valuation. The consensus target of $28.67 implies 8.1% appreciation, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $32 for EGBN, while the most conservative target is $25. The consensus of $28.67 represents the median expectation. These targets typically reflect 12-month expectations.
EGBN is moderately covered, with 14 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 6 have Buy ratings, 8 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month EGBN stock forecast based on 14 Wall Street analysts shows a consensus price target of $28.67, with estimates ranging from $25 (bear case) to $32 (bull case). The median consensus rating is "Hold".
EGBN trades at a forward P/E ratio of 15.9x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
EGBN appears fairly valued according to analysts, with a "Hold" rating and minimal upside to the $28.67 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
EGBN analyst price targets range from $25 to $32, a 24% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $28.67 consensus represents the middle ground.